1Mevio E, Gorini E, positron emission Sbrocca M, et tomography ( management of cervical lymph nodes an unknown primary al. The role of PET ) in the metastases from [ J ]. Acta Otorhinolaryngol Ital, 2004,24 (6) : 342 - 347.
2Van't-Veer Li, Weigelt B. Road map to metastasis [J]. Nat Med,2003,9(8) :999-1000.
4van de Wouw AJ,Janssen-Heijnen ML,Coebergh JW, et al. Epidemiology of unknown primary tumours; incidence and population-based survival of 1 285 patients in Southeast Netherlands, 1984-1992[J]. Eur J Cancer, 2002,38 (3) : 409- 413.
5Kambhu SA, Kelsen DP, Fiore J, et al. Metastatic adenocarcinoma of unknown primary site. Prognostic variables and treatment results [J]. Am J Clin Oncol, 1990,13(1):55-60.
6Hainsworth JD, Burris HA III, Calvert SW, et al. Gemcitabine, carboplatin, and paclitaxel for patients with carcinorma of unknown primary site:a phase Ⅱ trial of the Minnie Pearl Cancer Research Network [J]. Cancer Invest, 2001,19(4) : 335-339.
7Piga A, Nortilli R, Cetto, GL, et al. Carboplatin, doxorubicin and etoposide in the treatment of tumours of unknown primary site [J]. Br J Cancer, 2004, 90 (10) : 1898-1904.
